<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Between 1971 and 1989 we have treated 19 patients with <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> by marrow transplantation from their HLA-identical siblings following conditioning with 200 mg/kg <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (Cy) administered over a period of 4 days </plain></SENT>
<SENT sid="1" pm="."><plain>One patient failed to engraft by day 34 and was given a second transplantation </plain></SENT>
<SENT sid="2" pm="."><plain>He died from <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> 15 days after the second transplantation </plain></SENT>
<SENT sid="3" pm="."><plain>Eighteen patients had sustained engraftment </plain></SENT>
<SENT sid="4" pm="."><plain>Six patients developed <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-vs.-host disease</z:e> (GVHD) and two of these patients died 2.8 and 3.3 months after transplantation </plain></SENT>
<SENT sid="5" pm="."><plain>Fifteen patients are surviving 4 to 24 (median 13) years after transplantation, while one patient died in a car accident 17 years after successful transplantation </plain></SENT>
<SENT sid="6" pm="."><plain>Six of the surviving patients developed <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD </plain></SENT>
<SENT sid="7" pm="."><plain>Two of the patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD had preceding <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD and four did not </plain></SENT>
<SENT sid="8" pm="."><plain>Five of the six patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD received donor buffy coat cells in addition to the marrow inoculum to prevent graft rejection </plain></SENT>
<SENT sid="9" pm="."><plain>Twelve of the 15 surviving patients have Karnofsky performance scores of 100% </plain></SENT>
<SENT sid="10" pm="."><plain>One patient, living more than 4 years after transplantation, has a Karnofsky score of 40% because of persistent <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> following non-A, non-B <z:hpo ids='HP_0012115'>hepatitis</z:hpo> with hepatic <z:hpo ids='HP_0001259'>coma</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Two patients developed <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> 12 and 18 years after transplantation, respectively </plain></SENT>
<SENT sid="12" pm="."><plain>Except for mild <z:mp ids='MP_0002899'>fatigue</z:mp> and mildly elevated liver function tests, these patients are doing well with Karnofsky performance scores between 95 and 100% </plain></SENT>
<SENT sid="13" pm="."><plain>One patient developed severe <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> 10 years after transplantation, decreasing his Karnofsky performance score to 80% </plain></SENT>
<SENT sid="14" pm="."><plain>Serum samples before and after transplantation from 13 patients were tested for <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus (HBV) DNA and <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus (HCV) <z:chebi fb="40" ids="33697">RNA</z:chebi> by polymerase chain reaction (PCR) </plain></SENT>
<SENT sid="15" pm="."><plain>Only one patient tested positive for HCV <z:chebi fb="40" ids="33697">RNA</z:chebi> before transplantation </plain></SENT>
<SENT sid="16" pm="."><plain>Seven of 15 sera were <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C <z:chebi fb="40" ids="33697">RNA</z:chebi>-positive posttransplantation, but only one of these patients has developed active <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C </plain></SENT>
<SENT sid="17" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 13 patients were were negative for <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B surface antigen and HBV DNA </plain></SENT>
<SENT sid="18" pm="."><plain>Only one patient had IgM antibodies against <z:hpo ids='HP_0012115'>hepatitis</z:hpo> A virus (HAV) before transplantation, which suggested HAV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="19" pm="."><plain><z:hpo ids='HP_0012115'>Hepatitis</z:hpo>-associated <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> apparently was caused in most patients by a non-A, non-B, non-C agent </plain></SENT>
<SENT sid="20" pm="."><plain>HLA-identical marrow transplantation for <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with Cy as conditioning regimen is well-tolerated and has a long-term event-free survival in excess of 80%, not different from results of marrow transplantations for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> of other etiologies </plain></SENT>
</text></document>